Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corticosteroid vs Lidocaine Injections with Physiotherapy for Pes Anserine Bursitis and Knee OA
NCT04887844Completed
- Sponsor
- Bolu Abant Izzet Baysal University
- Start
- Mar 2019
- Primary completion
- Mar 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of lidocaine and betamethasone in Pes anserine bursitis (PAB) (3 arms), sponsored by Bolu Abant Izzet Baysal University. Primary endpoint: Visual Analogue Scale at 8 weeks. Started Mar 2019; status: completed.
02
Drugs
lidocainebetamethasone
03
Conditions
Pes anserine bursitis (PAB)
Beyond the preview
Go deeper on NCT04887844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04887844.